ArticleHNO2012

[Bevacizumab in therapy-refractory epistaxis: case report of low-dose antibody therapy for hereditary hemorrhagic telangiectasia].

C Rohrmeier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.